Sign InBreakout Stocks of Week 29 @ FRA
NASDAQ was up last week (week 28) by 1.81% ending at 26,281.61 points after gaining 468.18 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Ishares Msci China A Ucits Etf FRA:36BZ. This stock has had a buy signal since Jul 09, 2026 when the price was 5.48€ , but have so far fallen -1.24% to 5.41€. Some other companies are on our watchlist to, among these are Bechtle AG FRA:BC8 HOCHTIEF Aktiengesellschaft FRA:HOT and Lyxor Ftse China A50 Ucits Etf FRA:C024 which all got a breakout pattern emerging.
| Date | Company | Price | Week 29 |
|---|---|---|---|
| Ishares Msci China A Ucits Etf | 5.41€ | 5.07€ | -6.19% |
| Bechtle Ag | 30.56€ | 30.28€ | -0.92% |
| Hochtief Aktiengesellschaft | 455.20€ | 455.60€ | 0.0879% |
| Lyxor Ftse China A50 Ucits Etf | 176.02€ | 165.72€ | -5.85% |
The Ishares Msci China A Ucits Etf ETF price fell by -1.24% on the last day (Friday, 10th Jul 2026) from 5.48€ to 5.41€. During the last trading day the ETF fluctuated 0.482% from a day low at 5.39€ to a day high of 5.42€. The price has fallen in 7 of the last 10 days and is down by -2.42% for this period. Volume has increased on the last day by 400 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 400 thousand shares were bought and sold for approximately 2.16€ million.
Ishares Msci China A Ucits Etf holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
The Bechtle AG stock price gained 0.460% on the last trading day (Friday, 10th Jul 2026), rising from 30.42€ to 30.56€. During the last trading day the stock fluctuated 1.79% from a day low at 30.12€ to a day high of 30.66€. The price has been going up and down for this period, and there has been a -0.84% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 318 thousand more shares were traded than the day before. In total, 318 thousand shares were bought and sold for approximately 9.71€ million.
Bechtle AG holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Bechtle AG:
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. It has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.
The HOCHTIEF Aktiengesellschaft stock price fell by -2.36% on the last day (Friday, 10th Jul 2026) from 466.20€ to 455.20€. During the last trading day the stock fluctuated 3.26% from a day low at 454.40€ to a day high of 469.20€. The price has fallen in 7 of the last 10 days and is down by -8.56% for this period. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 47 thousand shares were bought and sold for approximately 21.54€ million.
The HOCHTIEF Aktiengesellschaft stock holds several negative signals and despite the positive trend, we believe HOCHTIEF Aktiengesellschaft will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About HOCHTIEF Aktiengesellschaft:
HOCHTIEF Aktiengesellschaft engages in the construction business worldwide. The company operates through HOCHTIEF Americas, HOCHTIEF Asia Pacific, HOCHTIEF Europe, and Abertis Investment divisions. The HOCHTIEF Americas division provides building and transportation infrastructure construction services primarily in the United States and Canada. The HOCHTIEF Asia Pacific division offers infrastructure construction, resource and mineral processing services, engineering and technical services, and maintenance services in the Asia-Pacific region. This division also undertakes public-private partnerships (PPP). The HOCHTIEF Europe division provides services primarily for infrastructure and building construction projects, as well as PPP in transportation, energy, social, and urban infrastructure. It also offers engineering services, including virtual construction, and facility management; and designs, develops, builds, operates, and manages real estate and infrastructure. The Abertis Investment segment operates toll roads in France, Spain, North America, Brazil, Chile, and Mexico. The company also provides insurance products; and reinsurance products primarily for contractors' casualty and surety, subcontractor default, liability, and occupational accident insurance. HOCHTIEF Aktiengesellschaft was founded in 1873 and is headquartered in Essen, Germany. HOCHTIEF Aktiengesellschaft operates as a subsidiary of ACS, Actividades de Construcción y Servicios, S.A.
The Lyxor Ftse China A50 Ucits Etf ETF price fell by -1.39% on the last day (Friday, 10th Jul 2026) from 178.50€ to 176.02€. During the last trading day the ETF fluctuated 0.524% from a day low at 175.64€ to a day high of 176.56€. The price has been going up and down for this period, and there has been a -2.02% loss for the last 2 weeks. Volume has increased on the last day by 25 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 31 thousand shares were bought and sold for approximately 5.49€ million.
Lyxor Ftse China A50 Ucits Etf holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this ETF.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
FOX
$50.81
|
2.22% | Jul 27 |
UNFI
$49.05
|
3.63% | Jul 27 |
BIIB
$202.19
|
0.376% | Jul 24 |
TSCO
$30.32
|
1.48% | Jul 23 |
|
S
SW
$43.71
|
5.17% | Jul 23 |
